Andrea A. Robitzki

Andrea A. Robitzki

Auto-generated profile, based on publicly available information

Andrea A. Robitzki

Centre for Biotechnology and Biomedicine (BBZ), Universität Leipzig, Division of Molecular Biological-Biochemical Processing Technology, Deutscher Platz 5, 04103, Leipzig, Germany.

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2008 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
DKDaniel Kloß
Daniel Kloß
MFMichael Fischer
Michael Fischer
ARAndrée Rothermel
Andrée Rothermel
JSJan C. Simon
Jan C. Simon
ARAndrea A. Robitzki
Andrea A. Robitzki
Close to realistic responses to anti-cancer drugs are not adequately provided in monolayer or single cells assays. 3-dimensional multicellular cultures (spheroids) mimicking in vivo-like conditions are established as cell biological models for microtumors/metastases. For a non-invasive real-time monitoring of the electrical parameters of such spheroid cultures we designed, fabricated and tested a 3D multifunctional electrode-based microcavity array. In a non-adherent assay acute tests with tumor spheroids were done maintaining their spherical shape and cellular arrangement. The sensor chip with 15 individual square microcavities containing four gold electrodes each was used for impedance spectroscopy to analyze the tissue models in terms of morphological and structural changes. Cell type specific differences in the spectra and varying responses to several anti-tumor drugs were found. Further development of the prototype will provide a promising tool for the use in pharmacological high-throughput studies.

12 January 2008 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
DKDaniel Kloß
Daniel Kloß
RKRandy Kurz
Randy Kurz
HJHeinz-Georg Jahnke
Heinz-Georg Jahnke
MFMichael Fischer
Michael Fischer
ARAndrée Rothermel
Andrée Rothermel
ARAndrea A. Robitzki
Andrea A. Robitzki

1 February 2019 in Biosensors and Bioelectronics
Verified
Journal Article
Open access
SFStephan Fleischer
Stephan Fleischer
HJHeinz-Georg Jahnke
Heinz-Georg Jahnke
EFEnrico Fritsche
Enrico Fritsche
MGMathilde Girard
Mathilde Girard
ARAndrea A. Robitzki
Andrea A. Robitzki
Human pluripotent stem cell derived cardiomyocytes are a promising cell source for research and clinical applications like investigation of cardiomyopathies and therefore, identification and testing of novel therapeutics as well as for cell based therapy approaches. However, actually it´s a challenge to generate matured adult cardiomyocyte-like phenotype in a reasonable time. Moreover, there is a lack of applicable non-invasive label-free monitoring techniques providing quantitative parameters for analysing the culture stability and maturation status. In this context, we established an efficient protocol based on a combined differentiation of hiPSC in 2D cultures followed by a forced reaggregation step that leads to highly enriched (>90% cardiomyocytes) cardiomyocyte clusters. Interestingly, 3D cultures revealed an accelerated maturation as well as phenotype switch from atrial to ventricular cardiomyocytes. More strikingly using combined impedimetric and electrophysiological monitoring the high functionality and long-term stability of 3D cardiomyocyte cultures, especially in comparison to 2D cultures could be demonstrated. Additionally, chronotropic as well as QT-prolongation causing reference compounds were used for validating the cardio specific and sensitive reaction over the monitored time range of more than 100 days. Thus, the approach of multiparametric bioelectronic monitoring offers capabilities for the long-term quantitative analysis of hiPS derived cardiomyocyte culture functionality and long-term stability. Moreover, the same multiparametric bioelectronic platform can be used in combination with validated long-term stable cardiomyocyte cultures for the quantitative detection of compound induced effects. This could pave the way for more predictive in vitro chronic/repeated dose cardiotoxicity testing assays.

7 November 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DSDiana Seidel
Diana Seidel
DKDana Krinke
Dana Krinke
HJHeinz-Georg Jahnke
Heinz-Georg Jahnke
AHAnika Hirche
Anika Hirche
DKDaniel Kloß
Daniel Kloß
ARAndrea Robitzki
Andrea Robitzki
Tauopathies including Alzheimer’s disease represent one of the major health problems of aging population worldwide. Therefore, a better understanding of tau-dependent pathologies and consequently, tau-related intervention strategies is highly demanded. In recent years, several tau-focused therapies have been proposed with the aim to stop disease progression. However, to develop efficient active pharmaceutical ingredients for the broad treatment of Alzheimer’s disease patients, further improvements are necessary for understanding the detailed neurodegenerative processes as well as the mechanism and side effects of potential active pharmaceutical ingredients (API) in the neuronal system. In this context, there is a lack of suitable complex in vitro cell culture models recapitulating major aspects of taupathological degenerative processes in sufficient time and reproducible manner. Herewith, we describe a novel 3D SH-SY5Y cell-based, tauopathy model that shows advanced characteristics of matured neurons in comparison to monolayer cultures without the need of artificial differentiation promoting agents. Moreover, the recombinant expression of a novel highly pathologic fourfold mutated human tau variant lead to a fast and emphasized degeneration of neuritic processes. The neurodegenerative effects could be analyzed in real time and with high sensitivity using our unique microcavity array-based impedance spectroscopy measurement system. We were able to quantify a time- and concentration-dependent relative impedance decrease when Alzheimer’s disease-like tau pathology was induced in the neuronal 3D cell culture model. In combination with the collected optical information, the degenerative processes within each 3D-culture could be monitored and analyzed. More strikingly, tau-specific regenerative effects caused by tau-focused active pharmaceutical ingredients could be quantitatively monitored by impedance spectroscopy. Bringing together our novel complex 3D cell culture taupathology model and our microcavity array-based impedimetric measurement system, we provide a powerful tool for the label-free investigation of tau-related pathology processes as well as the high content analysis of potential active pharmaceutical ingredient candidates.

1 May 2015 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
MEMarie Eichler
Marie Eichler
HJHeinz-Georg Jahnke
Heinz-Georg Jahnke
DKDana Krinke
Dana Krinke
AMAstrid Müller
Astrid Müller
SSSabine Schmidt
Sabine Schmidt
ARAndrea A. Robitzki
Andrea A. Robitzki

1 December 2016 in Biosensors and Bioelectronics
Verified
Journal Article
Open access
DSDiana Seidel
Diana Seidel
JOJanine Obendorf
Janine Obendorf
BEBeate Englich
Beate Englich
HJHeinz-Georg Jahnke
Heinz-Georg Jahnke
VSVesselina Semkova
Vesselina Semkova
ARAndrea A. Robitzki
Andrea A. Robitzki
In today's neurodevelopment and -disease research, human neural stem/progenitor cell-derived networks represent the sole accessible in vitro model possessing a primary phenotype. However, cultivation and moreover, differentiation as well as maturation of human neural stem/progenitor cells are very complex and time-consuming processes. Therefore, techniques for the sensitive non-invasive, real-time monitoring of neuronal differentiation and maturation are highly demanded. Using impedance spectroscopy, the differentiation of several human neural stem/progenitor cell lines was analyzed in detail. After development of an optimum microelectrode array for reliable and sensitive long-term monitoring, distinct cell-dependent impedimetric parameters that could specifically be associated with the progress and quality of neuronal differentiation were identified. Cellular impedance changes correlated well with the temporal regulation of biomolecular progenitor versus mature neural marker expression as well as cellular structure changes accompanying neuronal differentiation. More strikingly, the capability of the impedimetric differentiation monitoring system for the use as a screening tool was demonstrated by applying compounds that are known to promote neuronal differentiation such as the γ-secretase inhibitor DAPT. The non-invasive impedance spectroscopy-based measurement system can be used for sensitive and quantitative monitoring of neuronal differentiation processes. Therefore, this technique could be a very useful tool for quality control of neuronal differentiation and moreover, for neurogenic compound identification and industrial high-content screening demands in the field of safety assessment as well as drug development.